Search Results - "Distler, Alfiya"
-
1
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
Published in Nature communications (24-10-2017)“…Signal transducer and activator of transcription 3 (STAT3) is phosphorylated by various kinases, several of which have been implicated in aberrant fibroblast…”
Get full text
Journal Article -
2
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Published in Annals of the rheumatic diseases (01-05-2016)“…Nintedanib is a tyrosine kinase inhibitor that has recently been shown to slow disease progression in idiopathic pulmonary fibrosis in two replicate phase III…”
Get more information
Journal Article -
3
Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss
Published in Annals of the rheumatic diseases (01-06-2016)“…Autophagy has recently been shown to regulate osteoclast activity and osteoclast differentiation. Here, we aim to investigate the impact of autophagy…”
Get more information
Journal Article -
4
Signature of circulating microRNAs in osteoarthritis
Published in Annals of the rheumatic diseases (01-03-2015)“…Osteoarthritis is the most common form of arthritis and a major socioeconomic burden. Our study is the first to explore the association between serum microRNA…”
Get more information
Journal Article -
5
Author Correction: Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
Published in Nature communications (08-12-2021)Get full text
Journal Article -
6
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
Published in Annals of the rheumatic diseases (01-08-2015)“…Stimulators of the soluble guanylate cyclase (sGC) have recently been shown to inhibit transforming growth factor-β signalling. Here, we aimed to demonstrate…”
Get more information
Journal Article -
7
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
Published in Annals of the rheumatic diseases (01-04-2013)“…Epigenetic modifications such as DNA methylation and histone acetylation have been implicated in the pathogenesis of systemic sclerosis. However, histone…”
Get more information
Journal Article -
8
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability
Published in Annals of the rheumatic diseases (01-06-2014)“…The morphogen pathways Hedgehog, Wnt and Notch are attractive targets for antifibrotic therapies in systemic sclerosis. Interference with stem cell…”
Get more information
Journal Article -
9
Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease
Published in Blood (04-10-2012)“…Chronic graft-versus-host disease (cGVHD) is a prognosis limiting complication of allogeneic stem cell transplantation. The molecular mechanisms underlying…”
Get full text
Journal Article -
10
Cardiomyopathy in Murine Models of Systemic Sclerosis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-02-2015)“…Objective Cardiomyopathy has emerged as a leading cause of death in patients with systemic sclerosis (SSc). However, the pathogenesis of SSc‐related…”
Get full text
Journal Article -
11
Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis
Published in Nature medicine (01-02-2015)“…NR4A1 is shown to be an endogenous inhibitor of TGF-β-induced fibrosis and represents a therapeutic target for this condition. Mesenchymal responses are an…”
Get full text
Journal Article -
12
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
Published in Annals of the rheumatic diseases (01-06-2014)“…Activated Wnt signalling with decreased expression of endogenous inhibitors has recently been characterised as a central pathomechanism in systemic sclerosis…”
Get more information
Journal Article -
13
Vitamin D receptor regulates TGF-β signalling in systemic sclerosis
Published in Annals of the rheumatic diseases (01-03-2015)“…Vitamin D receptor (VDR) is a member of the nuclear receptor superfamily. Its ligand, 1,25-(OH)2D, is a metabolically active hormone derived from vitamin D3…”
Get more information
Journal Article -
14
Autophagy regulates TNFα-mediated joint destruction in experimental arthritis
Published in Annals of the rheumatic diseases (01-05-2013)“…Autophagy is a homeostatic process to recycle dispensable and damaged cell organelles. Dysregulation of autophagic pathways has recently been implicated in the…”
Get more information
Journal Article -
15
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
Published in Annals of the rheumatic diseases (01-10-2014)“…High levels of vascular endothelial growth factor (VEGF), a key angiogenic factor, are present in patients with systemic sclerosis (SSc), but its role in the…”
Get more information
Journal Article -
16
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment
Published in Annals of the rheumatic diseases (01-08-2017)“…Janus kinase 2 (JAK2) has recently been described as a novel downstream mediator of the pro-fibrotic effects of transforming growth factor-β. Although JAK2…”
Get more information
Journal Article -
17
Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse
Published in British journal of pharmacology (01-09-2020)“…Background and Purpose Genetic deletion and pharmacological studies suggest a role for lysophosphatidic acid (LPA1) receptor in fibrosis. We investigated the…”
Get full text
Journal Article -
18
Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling
Published in Annals of the rheumatic diseases (01-07-2015)“…We have previously described the antifibrotic role of the soluble guanylate cyclase (sGC). The mode of action, however, remained elusive. In the present study,…”
Get more information
Journal Article -
19
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Published in Annals of the rheumatic diseases (01-07-2013)“…Fibrosis is a major socioeconomic burden, but effective antifibrotic therapies are not available in the clinical routine. There is growing evidence for a…”
Get more information
Journal Article -
20
Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
Published in Annals of the rheumatic diseases (01-09-2013)“…Canonical Wnt signalling has recently emerged as a key mediator of fibroblast activation and tissue fibrosis in systemic sclerosis. Here, we investigated…”
Get more information
Journal Article